SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Kronbichler Andreas)
 

Sökning: WFRF:(Kronbichler Andreas) > COVID-19 outcomes i...

  • Gauckler, PhilippMed Univ Innsbruck, Austria (författare)

COVID-19 outcomes in patients with a history of immune-mediated glomerular diseases

  • Artikel/kapitelEngelska2023

Förlag, utgivningsår, omfång ...

  • FRONTIERS MEDIA SA,2023
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:liu-198507
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-198507URI
  • https://doi.org/10.3389/fimmu.2023.1228457DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:153784673URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Funding Agencies|The authors thank Lalit Kaltenbach for his support with the creation and administration of the REDCap database.
  • Introduction: Patients with immune-mediated glomerular diseases are considered at high risk for severe COVID-19 outcomes. However, conclusive evidence for this patient population is scarce.Methods: We created a global registry and retrospectively collected clinical data of patients with COVID-19 and a previously diagnosed immune-mediated glomerular disease to characterize specific risk factors for severe COVID-19 outcomes.Results: Fifty-nine patients with a history of immune-mediated glomerular diseases were diagnosed with COVID-19 between 01.03.2020 and 31.08.2021. Over a mean follow-up period of 24.79 +/- 18.89 days, ten patients (16.9%) developed acute kidney injury. Overall, 44.1% of patients were managed in an outpatient setting and therefore considered as having "non-severe" COVID-19, while 55.9% of patients had severe COVID-19 requiring hospitalization including worse outcomes. Comparing both groups, patients with severe COVID-19 were significantly older (53.55 +/- 17.91 versus 39.77 +/- 14.95 years, p = .003), had lower serum albumin levels at presentation (3.00 +/- 0.80 g/dL versus 3.99 +/- 0.68 g/dL, p = .016) and had a higher risk of developing acute kidney injury (27% versus 4%, p = .018). Male sex (p <.001) and ongoing intake of corticosteroids at presentation (p = .047) were also significantly associated with severe COVID-19 outcomes, while the overall use of ongoing immunosuppressive agents and glomerular disease remission status showed no significant association with the severity of COVID-19 (p = .430 and p = .326, respectively).Conclusion: Older age, male sex, ongoing intake of corticosteroids and lower serum albumin levels at presentation were identified as risk factors for severe COVID-19 outcomes in patients with a history of various immune-mediated glomerular diseases.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Kesenheimer, Jana S.Univ Innsbruck, Austria (författare)
  • Geetha, DuvuruJohns Hopkins Univ, MD USA (författare)
  • Odler, BalazsUniv Cambridge, England; Med Univ Graz, Austria (författare)
  • Eller, KathrinMed Univ Graz, Austria (författare)
  • Laboux, TimotheeUniv Lille, France; Univ Lille, France (författare)
  • Alberici, FedericoUniv Brescia, Italy; Azienda Socio Sanit Territoriale ASST Spedali Civi, Italy (författare)
  • Zappa, MattiaUniv Brescia, Italy; Azienda Socio Sanit Territoriale ASST Spedali Civi, Italy (författare)
  • Chebotareva, NatashaSechenov First Moscow State Med Univ, Russia (författare)
  • Moiseev, SergeySechenov First Moscow State Med Univ, Russia (författare)
  • Bonilla, MarcoNorthwell Hlth, NY USA (författare)
  • Jhaveri, Kenar D.Northwell Hlth, NY USA (författare)
  • Oniszczuk, JulieParis East Univ, France (författare)
  • Audard, VincentParis East Univ, France (författare)
  • Costa, DeniseUniv Fed Pernambuco, Brazil (författare)
  • Mastroianni-Kirsztajn, GiannaUniv Fed Sao Paulo, Brazil (författare)
  • Bruchfeld, AnnetteKarolinska Institutet,Linköpings universitet,Avdelningen för diagnostik och specialistmedicin,Medicinska fakulteten,Region Östergötland, Njurmedicinska kliniken US,Karolinska Inst, Sweden(Swepub:liu)anbru14 (författare)
  • Muto, MasahiroJuntendo Univ, Japan (författare)
  • Windpessl, MartinKlinikum Wels Grieskirchen, Austria (författare)
  • Mayer, GertMed Univ Innsbruck, Austria (författare)
  • Kronbichler, AndreasMed Univ Innsbruck, Austria; Univ Cambridge, England (författare)
  • Med Univ Innsbruck, AustriaUniv Innsbruck, Austria (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Frontiers in Immunology: FRONTIERS MEDIA SA141664-3224

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy